Bandingkan Harga & Kinerja Intikeramik Alamasri Industri Tbk. (IKAI) vs Indofarma Tbk. (INAF)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Intikeramik Alamasri Industri Tbk. dan Indofarma Tbk.: Intikeramik Alamasri Industri Tbk. diperdagangkan di Rp20 (kapitalisasi pasar 279,42 M, volume 24 jam 10,68 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Indofarma Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| IKAI | INAF | |
|---|---|---|
Kapitalisasi Pasar | 279,42 M | 390,51 M |
Volume | 10,68 jt | — |
Lot | 106,77 rb | — |
Perputaran | 214,53 jt | — |
Harga Rata-rata | 20,09 | — |
Nilai Transaksi | 214,53 jt | — |
Harga Ekuilibrium Indikatif | 20 | — |
Volume Ekuilibrium Indikatif | 10,92 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Intikeramik Alamasri Industri Tbk.
PT Intikeramik Alamasri Industri Tbk (the Company) was established under the name PT Intikeramik Alamasri Indah based on notarial deed No. 38 dated June 26, 1991 and was amended with notarial deed No. 16 dated December 14, 1991, both made by Raden Muhammad Hendarmawan, S.H., Notary in Jakarta. PT Intikeramik Alamasri Industri Tbk is the pioneer of large-scale porcelain tile manufacture in Indonesia and one of the largest producers in the Asia Pacific region. Porcelain tiles are superior in term of strength, durability and design versatility to natural stone as well as other synthetics such as glazed tiles. Porcelain is attractive and affordable for use in both commercial and residential developments and has strong following among international architects and interior designers. Intikeramik is seeking to build a leading profile in markets across Europe, America and Asia drawing upon its reputation for consistency, advanced manufacturing technology, a low cost base and substantial available capacity. The company has consolidation production capacity 6,600,000 m2 /year.
Selengkapnya di halaman IKAI →Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →
